Roundtable event on patient reach with PGIM Fixed Income and Jennison Associates - Meeting Report

By tracking patient reach metrics, the pharmaceutical industry is gaining a clearer view of gaps in access to medicine and strengthening efforts to reach patients in need, a practice increasingly recognised by investors as a key indicator of sustainable, responsible business.

To exchange perspectives on improving patient reach strategies, the Access to Medicine Foundation, in collaboration with PGIM Fixed Income and Jennison Associates, organised a high-level event alongside the United Nations General Assembly in New York.

The meeting convened 40 participants, including members of the institutional investor community and pharmaceutical companies. Under the Chatham House Rule, attendees engaged in an open dialogue on the industry’s progress in tracking and utilising patient reach metrics, and where progress still needs to be made.

Report insights 

Discussions centred around how companies can expand and improve their existing patient reach strategies while balancing economic viability. The meeting report captures key themes and strategies from the dialogue, including:

• Setting clear goals and demonstrating measurable progress

• Linking patient reach to financial performance

• Embedding sustainability into access programmes

• Reporting regularly and transparently to build trust and accountability

• Prioritising product affordability in LMIC strategies

You can read the full PDF of the meeting report for more details and key takeaways from the meeting.

Learn more about how we work with investors

The Access to Medicine Foundation works closely with the investor community to accelerate progress on global health. Through data-driven insights and collaborative initiatives, we equip investors with the tools to engage companies on access to medicine, track performance and drive long-term sustainable impact.